Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 7/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 6/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexanoate SCHEMBL19406559 | 0.99 | FABP3 (0.42) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Myristic Acid SCHEMBL29183500 | 0.97 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Palmitic Acid SCHEMBL28783450 | 0.97 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Palmitic Acid SCHEMBL28783480 | 0.97 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Palmitic Acid SCHEMBL28783479 | 0.97 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Palmitic Acid SCHEMBL28783485 | 0.97 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Dodecanoate SCHEMBL28783501 | 0.97 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Myristic Acid SCHEMBL29183501 | 0.97 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Myristic Acid SCHEMBL28783517 | 0.97 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Myristic Acid SCHEMBL28783489 | 0.97 | FABP3 (0.44) | FABP3MEN1HSP90AA1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12054578-B2 | Process for producing porous materials | AEROGEL-IT GMBH (DE) | 2024-08-06 | — | — | US | disclosed |
| EP-3405509-B1 | PROCESS FOR PRODUCING POROUS MATERIALS | AEROGEL IT GMBH (DE) | 2023-07-12 | — | — | EP | disclosed |
| CN-110914326-B | Method for producing porous material | 埃力格-伊特有限责任公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-108473658-B | Method for producing porous material | 巴斯夫欧洲公司 | 2022-08-26 | — | — | CN | disclosed |
| US-20220098384-A1 | Process for producing porous materials | BASF SE (DE) | 2022-03-31 | — | — | US | disclosed |
| US-11248101-B2 | Process for producing porous materials | BASF SE (DE) | 2022-02-15 | — | — | US | disclosed |
| EP-3911694-A1 | PROCESS FOR PRODUCING POROUS MATERIALS | BASF SE (DE) | 2021-11-24 | — | — | EP | disclosed |
| CN-113302232-A | Method for producing porous material | 巴斯夫欧洲公司 | 2021-08-24 | — | — | CN | disclosed |
| US-20210139633-A1 | PROCESS FOR PRODUCING POROUS MATERIALS | BASF SE (DE) | 2021-05-13 | — | — | US | disclosed |
| US-20210139662-A1 | POROUS MATERIALS WITH SUPERIOR REVERSIBLE WATER UPTAKE | BASF SE (DE) | 2021-05-13 | — | — | US | disclosed |
| US-20170088962-A1 | CUSTOM IONIC LIQUID ELECTROLYTES FOR ELECTROLYTIC DECARBOXYLATION | ENLIGHTEN INNOVATIONS INC. (CA) | 2017-03-30 | — | — | US | disclosed |
| WO-2017050679-A1 | PROCESS FOR PRODUCING POROUS MATERIALS | BASF SE (DE) | 2017-03-30 | — | — | WO | disclosed |
| EP-3122808-A1 | PROCESS FOR PRODUCING POROUS MATERIALS | BASF SE (DE) | 2017-02-01 | — | — | EP | disclosed |
| US-9493882-B2 | Custom ionic liquid electrolytes for electrolytic decarboxylation | CERAMATEC, INC. (US) | 2016-11-15 | — | — | US | disclosed |
| WO-2016150684-A1 | PROCESS FOR PRODUCING POROUS MATERIALS COMPRISING A CATALYST SYSTEM | BASF SE (DE) | 2016-09-29 | — | — | WO | disclosed |
| US-20160254098-A1 | METHOD FOR PREPARING IONIC LIQUID HAVING CARBOXYLIC ACID ANION USING MICROREACTOR | CHEMTECH RESEARCH INCORPORATION (KR) | 2016-09-01 | — | — | US | disclosed |
| WO-2015144698-A1 | PROCESS FOR PRODUCING POROUS MATERIALS | BASF SE (DE) | 2015-10-01 | — | — | WO | disclosed |
| US-20140251821-A1 | CUSTOM IONIC LIQUID ELECTROLYTES FOR ELECTROLYTIC DECARBOXYLATION | CERAMATEC, INC. (US) | 2014-09-11 | — | — | US | disclosed |
| US-8591757-B2 | Electrolyte composition and ionic liquid | KANEKA CORPORATION (JP) | 2013-11-26 | — | — | US | disclosed |
| US-20100213402-A1 | ELECTROLYTE COMPOSITION AND IONIC LIQUID | KANEKA CORPORATION (JP) | 2010-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160254098-A1 | METHOD FOR PREPARING IONIC LIQUID HAVING CARBOXYLIC ACID ANION USING MICROREACTOR | HCN4, ASIC1, ASIC3 | FABP3 315/4885MEN1 1599/4885HSP90AA1 3114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.